LOM
KERX

Loeb Offshore Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Loeb Offshore Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-19,431
Closed -$196K – 258
2013
Q3 		$196K Buy
19,431
+9,431
+94% +$83.9K 0.06% 195
2013
Q2 		$75K Buy
+10,000
New +$78.1K 0.04% 131

Other funds holding KERX

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Loeb Offshore Management's KERX Position: Q4 2013 in Review

Loeb Offshore Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2013, closing a stake of 19,431 shares — an estimated $196K sold.

Loeb Offshore Management first reported a position in KERX in Q2 2013 and held it in 2 quarters. The position peaked at $196K in Q3 2013. 124 funds tracked by Wall St. Rank hold KERX as of Q4 2013.

  • Loeb Offshore Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Loeb Offshore Management sold 19,431 Keryx Biopharmaceuticals Inc shares in Q4 2013, an estimated $196K.
  • Loeb Offshore Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Loeb Offshore Management's Keryx Biopharmaceuticals Inc position peaked at $196K in Q3 2013.
  • 124 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2013.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.